Healthcare
Live Price
Offline$317.20
+0.33% today
1Y Change
+25.05%
Window
Jun 23, 2025 โ Jun 15, 2026
Coverage: 246 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Penumbra, Inc. (PEN) is a Healthcare stock with a market cap of $12.77B and listed on NYSE. The stock last traded around $317.20 and up 25.1% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +17.5%, EPS growth of +1169.4%, a dividend yield of 0.0%. What stands out right now is revenue +17.5%, EPS +1169.4%, free cash flow +18.8% with operating margin 13.5% and ROIC 9.9%. Valuation already assumes a fairly strong business story at P/E 71.8 and price/sales 9.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PEN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PEN
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PEN Max Drawdown
-21.44%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for PEN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
โ
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.